[1]
“Development and in vitro evaluation of polyurethane microparticles as carrier for bevacizumab: an alternative treatment for retinopathy of prematurity”, Int Curr Pharm J, vol. 3, no. 6, pp. 275–279, May 2014, doi: 10.3329/icpj.v3i6.18759.